Establishment of a human three-dimensional chip-based chondro-synovial coculture joint model for reciprocal cross talk studies in arthritis research.

Rheumatoid arthritis is characterised by a progressive, intermittent inflammation at the synovial membrane, which ultimately leads to the destruction of the synovial joint. The synovial membrane as the joint capsule's inner layer is lined with fibroblast-like synoviocytes that are the key player supporting persistent arthritis leading to bone erosion and cartilage destruction. While microfluidic models that model molecular aspects of bone erosion between bone-derived cells and synoviocytes have been established, RA's synovial-chondral axis has not yet been realised using a microfluidic 3D model based on human patient in vitro cultures. Consequently, we established a chip-based three-dimensional tissue coculture model that simulates the reciprocal cross talk between individual synovial and chondral organoids. When co-cultivated with synovial organoids, we could demonstrate that chondral organoids induce a higher degree of cartilage physiology and architecture and show differential cytokine response compared to their respective monocultures highlighting the importance of reciprocal tissue-level cross talk in the modelling of arthritic diseases.

[1]  T. Hughes,et al.  The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. , 2021, Immunity.

[2]  P. Ertl,et al.  An on-chip wound healing assay fabricated by xurography for evaluation of dermal fibroblast cell migration and wound closure , 2020, Scientific Reports.

[3]  P. Ertl,et al.  Stiffness Matters: Fine-Tuned Hydrogel Elasticity Alters Chondrogenic Redifferentiation , 2020, Frontiers in Bioengineering and Biotechnology.

[4]  N. Hacohen,et al.  Notch signaling drives synovial fibroblast identity and arthritis pathology , 2020, Nature.

[5]  A. Gyenesei,et al.  Microfluidic nutrient gradient–based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model , 2019, Materials today. Bio.

[6]  G. Superti-Furga,et al.  IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes , 2019, Experimental & Molecular Medicine.

[7]  P. Ertl,et al.  Characterization of four functional biocompatible pressure-sensitive adhesives for rapid prototyping of cell-based lab-on-a-chip and organ-on-a-chip systems , 2019, Scientific Reports.

[8]  S. Toegel,et al.  Galectins‐1 and ‐3 in Human Intervertebral Disc Degeneration: Non‐Uniform Distribution Profiles and Activation of Disease Markers Involving NF‐κB by Galectin‐1 , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  S. Raychaudhuri,et al.  Distinct fibroblast subsets drive inflammation and damage in arthritis , 2019, Nature.

[10]  P. Ertl,et al.  Effect of Spheroidal Age on Sorafenib Diffusivity and Toxicity in a 3D HepG2 Spheroid Model , 2019, Scientific Reports.

[11]  S. Peh,et al.  Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development , 2018, Cells.

[12]  Ting Zhao,et al.  A microfluidic chip-based co-culture of fibroblast-like synoviocytes with osteoblasts and osteoclasts to test bone erosion and drug evaluation , 2018, Royal Society Open Science.

[13]  P. Ertl,et al.  Engineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signaling. , 2018, Biomicrofluidics.

[14]  N. Hacohen,et al.  Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry , 2018, bioRxiv.

[15]  S. Monrad,et al.  Early Diagnosis and Treatment of Rheumatoid Arthritis. , 2018, Primary care.

[16]  Dongan Wang,et al.  Establishment of an in vitro three‐dimensional model for cartilage damage in rheumatoid arthritis , 2018, Journal of tissue engineering and regenerative medicine.

[17]  T. Takeuchi,et al.  Targeted antibody therapy and relevant novel biomarkers for precision medicine for rheumatoid arthritis , 2017, International immunology.

[18]  David J Mooney,et al.  Mechanical confinement regulates cartilage matrix formation by chondrocytes , 2017, Nature materials.

[19]  G. Burmester,et al.  Novel treatment strategies in rheumatoid arthritis , 2017, The Lancet.

[20]  D. Fox,et al.  Synovial cellular and molecular markers in rheumatoid arthritis , 2017, Seminars in Immunopathology.

[21]  Toshio Tanaka,et al.  The role and therapeutic targeting of IL-6 in rheumatoid arthritis , 2017, Expert review of clinical immunology.

[22]  A. Griffioen,et al.  Targeting non-canonical nuclear factor-&kgr;B signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis , 2017, Rheumatology.

[23]  A. Mantovani,et al.  Macrophage heterogeneity in the context of rheumatoid arthritis , 2016, Nature Reviews Rheumatology.

[24]  P. Taylor,et al.  A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective , 2016, Rheumatology International.

[25]  Yoshiya Tanaka,et al.  Contribution of the Interleukin‐6/STAT‐3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells , 2015, Arthritis & rheumatology.

[26]  R. Caporali,et al.  B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers , 2014, BioMed research international.

[27]  R. J. Baatenburg de Jong,et al.  Effects of transforming growth factor‐β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal‐derived mesenchymal stem cells , 2012, Journal of tissue engineering and regenerative medicine.

[28]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[29]  A. Kimura,et al.  IL‐6: Regulator of Treg/Th17 balance , 2010, European journal of immunology.

[30]  T. Thornhill,et al.  Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture. , 2010, Arthritis and rheumatism.

[31]  G. Burmester,et al.  Cells of the synovium in rheumatoid arthritis. Macrophages , 2007, Arthritis research & therapy.

[32]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[33]  A. Facchini,et al.  VEGF Production by Osteoarthritic Chondrocytes Cultured in Micromass and Stimulated by IL-17 and TNF-α , 2007, Connective tissue research.

[34]  M. Brenner,et al.  Cadherin-11 induces rheumatoid arthritis fibroblast-like synoviocytes to form lining layers in vitro. , 2006, The American journal of pathology.

[35]  A. Facchini,et al.  IL-17, IL-1β and TNF-α stimulate VEGF production by dedifferentiated chondrocytes , 2004 .

[36]  W. B. van den Berg,et al.  Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering. , 2002, Osteoarthritis and cartilage.

[37]  Denis Vivien,et al.  Differential effects of transforming growth factor‐β and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes , 1990, Journal of cellular physiology.

[38]  R. Thurlings,et al.  A three-dimensional model to study human synovial pathology. , 2019, ALTEX.